Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285133
Max Phase: Preclinical
Molecular Formula: C18H16N6
Molecular Weight: 316.37
Associated Items:
ID: ALA5285133
Max Phase: Preclinical
Molecular Formula: C18H16N6
Molecular Weight: 316.37
Associated Items:
Canonical SMILES: Cc1ccc(Nc2nc(N)nc3cc(-c4ccccc4)nn23)cc1
Standard InChI: InChI=1S/C18H16N6/c1-12-7-9-14(10-8-12)20-18-22-17(19)21-16-11-15(23-24(16)18)13-5-3-2-4-6-13/h2-11H,1H3,(H3,19,20,21,22)
Standard InChI Key: WSIJUPUWACMKBX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.37 | Molecular Weight (Monoisotopic): 316.1436 | AlogP: 3.43 | #Rotatable Bonds: 3 |
Polar Surface Area: 81.13 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.95 | CX LogP: 4.49 | CX LogD: 4.49 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.61 | Np Likeness Score: -1.54 |
1. Alizadeh SR, Ebrahimzadeh MA.. (2021) Pyrazolotriazines: Biological activities, synthetic strategies and recent developments., 223 [PMID:34147747] [10.1016/j.ejmech.2021.113537] |
Source(1):